Search - tctmd.com

Displaying 41 - 60 of 88

Sort: Relevancy | Date

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Conference News The Structural Heart Disease Summit 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Daily News

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

Todd Neale

May 23, 2018

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Shelley Wood

March 16, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Advertisement

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Modified Surgical MV Repair Stands Up to Replacement

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content